Discounts on Mounjaro to be implemented in UK pharmacies, as the American pharmaceutical company lessens the impact of price increases.

Mounjaro, a popular weight loss medication, is set to see a price increase from the 1st of September, following Eli Lilly's decision to bring UK prices in line with other European markets. The move comes after the UK had benefitted from "significantly lower" costs compared to its European counterparts.

The price change is likely to affect around 750,000 Brits who currently use Mounjaro for weight loss. Eli Lilly is working with private providers to maintain the affordability of Mounjaro, and these arrangements are expected to be passed onto patients.

Pharmacies and other private weight-loss services will apply their own mark-up on the weight loss jab, and patients should anticipate seeing a rise in prices from the 1st of September. However, pharmacies will access price rebates if they can as a way of keeping prices accessible.

Eli Lilly has announced a discounted deal for UK suppliers, with the highest dose of Mounjaro being sold for £247.50, down from an anticipated £330. Prices advertised in many pharmacies will already reflect this discount.

The Liberal Democrats have expressed concerns about the price increase and have called on the UK's competition regulator to launch an investigation into how President Trump's pharmaceutical policies might affect UK consumers. They have also suggested that the regulator should examine what sanctions can be issued against firms like Eli Lilly if they introduce sharp increases to UK drug prices.

The surge in Mounjaro's price may push customers towards unregulated black market alternatives, according to experts. Olivier Picard, Chair of the National Pharmacy Association, stated that the rebate will mitigate some of the impact of the price increase, but patients should still be prepared for higher costs.

Earlier this week, Mounjaro had asked its two British wholesalers to stop taking orders due to "unprecedented demand" ahead of the price rise. The Liberal Democrats have further called for an investigation into how President Trump's policies will affect UK consumers, citing the impact of White House pharmaceutical policies as an example.

Discounts on Mounjaro to be implemented in UK pharmacies, as the American pharmaceutical company lessens the impact of price increases.